Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann1,2, Astghik Voskanyan3, Michael Lauseker4
1ELN Foundation, Weinheim, Germany. hehlmann.eln@gmail.com.
Leukemia
|September 11, 2020
Summary
This study has a published amendment. Please refer to the link at the top of the paper for the most current information and findings.
Area of Science:
- Not specified
Context:
- The provided abstract does not contain sufficient information to populate this section.
Purpose:
- The abstract indicates an amendment has been published.
Summary:
- An amendment to this paper is now available.
Impact:
- Readers should consult the amended version for accurate information.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.2K
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.4K
Related Concept Videos
Disorders of Leukocytes
1.6K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.6K
Bone Marrow Sampling and Transplants
699
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
699
